- Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis. Estimated incidence, prevalence and mortality by country. J Am Med Assoc 1999; 282: 677–86.
- Roche PW, Riccas A, Winter N. BCG vaccination against tuberculosis: past disappointments and future hopes. Trends Microbiol 1995; 3: 397–401.
- Bloom BR, Fine PEM. The BCG experience: implications for future vaccines against tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection and control. Washington DC: American Society for Microbiology, 1994: pp. 541–57.
- Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537–44.
- McMurray DN. Recent advances in improved tuberculosis vaccines. Indian J Pediatr 2000; 67: S58–62.
- Wiegeshaus EH, Harding GE, McMurray DN, Grover AA, Smith DW. A cooperative evaluation of test systems used to assay tuberculosis vaccines. Bull World Health Organ 1971; 45: 543–50.
- Baldwin SL, D’Souza C, Roberts AD, Kelly BP, Frank AA, Liu MA, et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun 1998; 66: 2951–9.
- McMurray DN. A non-human primate model for preclinical testing of new tuberculosis vaccines. Clin Infect Dis 2000; 30: S210–2.
- Buddle BM, Keen D, Thomson A, Jowett G, McCarthy AR, Heslop J, et al. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res Vet Sci 1995; 59: 10–6.
- North RJ, Lacourse R, Ryan L. Vaccinated mice remain more susceptible to Mycobacterium tuberculosis infection initiated by the respiratory route than via the intravenous route. Infect Immun 1999; 67: 2010–2.
- Wiegeshaus EH, McMurray DN, Grover AA, Harding GE, Smith DW. Host-parasite relationships in experimental airborne tuberculosis. III. Relevance of microbial enumeration to acquired resistance in guinea pigs. Am Rev Respir Dis 1970; 102: 422–9.
- Dannenberg AM Jr. Rabbit model of tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection, and control. Washington DC: American Society for Microbiology, 1994: 149–56.
- Dannenberg AM Jr. Lurie’s tubercle-count method to test TB vaccine efficacy in rabbits. Front Biosci 1998; 3: c27–33.
- Smith DW, McMurray DN, Wiegeshaus EH, Grover AA, Harding GE. Host–parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and non-vaccinated guinea pigs. Am Rev Respir Dis 1970; 102: 937–49.
- Wiegeshaus EH, Balasubramanian V, Smith DW. Immunity to tuberculosis from the perspective of pathogenesis. Infect lmmun 1989; 57: 3671–6.
- Comstock GW. Field trials of tuberculosis vaccines: how could we have done better? Control Clin Trials 1994; 15: 247–76.
- Legranderie M, Ravisse P, Marchal G, Gheorghiu M, Balasubramanain V, Wiegeshaus EH, et al. BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route. Tuberc Lung Dis 1993; 74: 38–46.
- Dannenberg AM Jr. Cellular hypersensitivity and cellular immunity in the pathogenesis of tuberculosis: specificity, system and local nature, and associated macrophage enzymes. Bacteriol Rev 1968; 32: 85–102.
- Ho RS, Fok JS, Harding GE, Smith DW. Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia. J Infect Dis 1978; 138: 237–41.
- Smith DW. Protective effect of BCG in experimental tuberculosis. Adv Tuberc Res 1985; 22: 1–98.
- Hussein S, Curtis J, Akuffo H, Turk JL. Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T cell clones. Infect Immun 1987; 55: 564–7.
- Martin E, Kamath AT, Triccas JA, Britton WJ. Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4 + T cells. Infect Immun 2000; 68: 3090–6.
- Li Z, Howard A, Kelley C, Delogu G, Collins F, Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun 1999; 67: 4780–6.
- Dai G, McMurray DN. Altered cytokine production and impaired antimycobacterial immunity in protein-malnourished guinea pigs. Infect Immun 1998; 66: 3562–8.
- Silver RF, Li Q, Boom WH, Ellner JJ. Lymphocyte-dependent inhibition of growth of virulent Mycobacteriurn tuberculosis H37Rv within human monocytes: requirement for CD4 + T cells in purified protein derivative-positive, but not in purified protein derivative-negative, subjects. J Immunol 1998; 160: 2408–17.
- Andersen P, Smedegaard B. CD4 + T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice. Infect Immun 2000; 68: 621–9.
- Flynn JL, Scanga CA, Tanaka KE, Chan J. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 1998; 160: 1796–803.
- Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 1998; 6: 107–12.
- McMurray DN, Bartow RA, Mintzer CL. Impact of protein malnutrition on exogenous reinfection with Mycobacterium tuberculosis. Infect Immun 1989; 57: 1746–9.
- Turner J, Rhoades ER, Keen M, Belisle JT, Frank AA, Orme IM. Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode. Infect Immun 2000; 68: 1706–9.
- Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, Stavropoulos E, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999; 400: 269–71.
Scandinavian Journal of Infectious Diseases
Volume 33, 2001 - Issue 1